Hrt Financial LP Embecta Corp. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$15.0 - $22.17 $6.16 Million - $9.1 Million	-410,352 Reduced 93.41%	28,971 $436,000
Q2 2023 Aug 11, 2023	BUY	$21.6 - $30.69 $1.23 Million - $1.74 Million	56,764 Added 14.84%	439,323 $9.49 Million
Q1 2023 May 12, 2023	BUY	$23.07 - $32.77 $8.83 Million - $12.5 Million	382,559 New	382,559 $10.8 Million
Q3 2022 Nov 14, 2022	BUY	$24.0 - $33.42 $15.1 Million - $21.1 Million	630,275 New	630,275 $18.1 Million

397

52.9M

215K

83.3K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $819M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.